Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    April 2021
  1. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases. Reply.
    N Engl J Med. 2021;384:1378.
    PubMed    


  2. MRAVEC B
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377-1378.
    PubMed    


  3. GAFFNEY P, Gaffney R
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377.
    PubMed    


  4. CHEN CJ, Hu H, Liao WT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1376-1377.
    PubMed    


    February 2021
  5. THOMAS AS, Ma W, Wang Y
    Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.
    N Engl J Med. 2021;384:581-583.
    PubMed    


    December 2020
  6. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2020;383:2652-2664.
    PubMed    


    August 2020
  7. VITEK L, Tiribelli C
    Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation.
    N Engl J Med. 2020;383:684-686.
    PubMed    


    July 2020
  8. CHEN RY, Kung VL, Das S, Hossain MS, et al
    Duodenal Microbiota in Stunted Undernourished Children with Enteropathy.
    N Engl J Med. 2020;383:321-333.
    PubMed     Abstract available


    June 2020
  9. ESFAHANI K, Hudson M, Batist G
    Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy.
    N Engl J Med. 2020;382:2374-2375.
    PubMed    


    April 2020
  10. HABERMAN R, Axelrad J, Chen A, Castillo R, et al
    Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
    N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567.
    PubMed    


    March 2020
  11. BOHOSSIAN HB, Lopes EW, Roller LA, Ananthakrishnan AN, et al
    Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
    N Engl J Med. 2020;382:1042-1052.
    PubMed    


    January 2020
  12. SANDS BE, Schreiber S, Lirio RA
    Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
    N Engl J Med. 2020;382:93-94.
    PubMed    


  13. O'CONNOR DB, Lahiff C
    Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
    N Engl J Med. 2020;382:92-93.
    PubMed    


  14. BIEMANS VBC, Hoentjen F, Pierik MJ
    Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
    N Engl J Med. 2020;382:92.
    PubMed    


  15. SANDS BE, Marano C
    Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Reply.
    N Engl J Med. 2020;382:91.
    PubMed    


  16. ROWAN CR, Boland K, Harewood GC
    Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2020;382:91.
    PubMed    


    September 2019
  17. FARRELL RJ
    Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?
    N Engl J Med. 2019;381:1279-1281.
    PubMed    


  18. SANDS BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, et al
    Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
    N Engl J Med. 2019;381:1215-1226.
    PubMed     Abstract available


  19. SANDS BE, Sandborn WJ, Panaccione R, O'Brien CD, et al
    Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2019;381:1201-1214.
    PubMed     Abstract available


  20. LAI AR, Sheu L, Gensler LS, McQuaid K, et al
    A Terminal Event.
    N Engl J Med. 2019;381:970-976.
    PubMed    


    June 2019
  21. KHALILI H, O'Shea A, Robbins GK, Zukerberg LR, et al
    Case 19-2019: A 38-Year-Old Woman with Abdominal Pain and Fever.
    N Engl J Med. 2019;380:2461-2470.
    PubMed    


    March 2019
  22. COLAIANNI CA
    Informed.
    N Engl J Med. 2019;380:1099-1101.
    PubMed    


    July 2018
  23. PERRICONE G, Vangeli M
    Pyoderma Gangrenosum in Ulcerative Colitis.
    N Engl J Med. 2018;379:e7.
    PubMed    


    March 2018
  24. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    PubMed    


    February 2018
  25. KNUESEL SJ, Guseh JS 2nd, Karp Leaf R, Ciaranello AL, et al
    Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia.
    N Engl J Med. 2018;378:753-760.
    PubMed    


    August 2017
  26. KANNEGANTI TD
    Inflammatory Bowel Disease and the NLRP3 Inflammasome.
    N Engl J Med. 2017;377:694-696.
    PubMed    


  27. DAI C, Jiang M, Sun MJ
    Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496.
    PubMed    



  28. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;377:496-7.
    PubMed    


    July 2017
  29. DAVID JG
    The Chair Grant.
    N Engl J Med. 2017;377:108-109.
    PubMed    


    May 2017
  30. ESFAHANI K, Miller WH Jr
    Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    N Engl J Med. 2017;376:1989-91.
    PubMed    


  31. MILOSLAVSKY EM, Stone JH, Moy AP
    Case 14-2017 - A 20-Year-Old Man with Pain and Swelling of the Left Calf and a Purpuric Rash
    N Engl J Med. 2017;376:1868-1877.
    PubMed    


  32. FRIEDMAN S
    Tofacitinib for Ulcerative Colitis - A Promising Step Forward.
    N Engl J Med. 2017;376:1792-1793.
    PubMed    


  33. SANDBORN WJ, Su C, Sands BE, D'Haens GR, et al
    Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2017;376:1723-1736.
    PubMed     Abstract available


    March 2017
  34. KNIELING F, Neufert C, Hartmann A, Claussen J, et al
    Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity.
    N Engl J Med. 2017;376:1292-1294.
    PubMed    


    November 2016
  35. FEAGAN BG, Sandborn WJ, Gasink C, Jacobstein D, et al
    Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2016;375:1946-1960.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: